Cetlalimumab: Difference between revisions
m Protected "Cetlalimumab": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
||
Line 20: | Line 20: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
==Overview== | ==Overview== | ||
Line 26: | Line 26: | ||
{{humanmonoclonals}} | {{humanmonoclonals}} | ||
[[Category:Monoclonal antibodies]] | [[Category:Monoclonal antibodies]] | ||
[[Category:Cancer treatments]] | [[Category:Cancer treatments]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WS}} | {{WS}} |
Latest revision as of 23:42, 8 August 2012
WikiDoc Resources for Cetlalimumab |
Articles |
---|
Most recent articles on Cetlalimumab Most cited articles on Cetlalimumab |
Media |
Powerpoint slides on Cetlalimumab |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Cetlalimumab at Clinical Trials.gov Clinical Trials on Cetlalimumab at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Cetlalimumab
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Cetlalimumab Discussion groups on Cetlalimumab Patient Handouts on Cetlalimumab Directions to Hospitals Treating Cetlalimumab Risk calculators and risk factors for Cetlalimumab
|
Healthcare Provider Resources |
Causes & Risk Factors for Cetlalimumab |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Overview
Cetlalimumab is a human monoclonal antibody which is used to treat cancer.